Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Radiation Injuries × olaparib × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 60 Triple Negative Breast Neoplasms 26 Ovarian Neoplasms 16 Neoplasm Metastasis 8 Prostatic Neoplasms 7 Pancreatic Neoplasms 6 Fanconi Anemia, Complementation Group D1 4 Endometrial Neoplasms 4 Advanced Breast Cancer 4 Recurrence 3 Neoplasms 3 Small Cell Lung Carcinoma 2 Inflammatory Breast Neoplasms 2 Fallopian Tube Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Metastatic Breast Cancer 1 Thyroid Neoplasms 1 Thrombocytosis 1 Stomach Neoplasms 1 Sarcoma 1 Radiation Injuries 1 Primary Myelofibrosis 1 Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1

Interventions

Radiotherapy 4 Radiotherapy, Intensity-Modulated 2 Low-Level Light Therapy 2 Chemotherapy, Adjuvant 2 olaparib 1 Sodium Chloride 1 Respiratory Physiological Phenomena 1 Radiotherapy, Conformal 1 Radiation Dose Hypofractionation 1 Proton Therapy 1 Poly A 1 Oxygen 1 Mass Screening 1 Lymph Node Excision 1 Lovastatin 1 Hyperbaric Oxygenation 1 Gene Expression Profiling 1 G(M1) Ganglioside 1 Flow Cytometry 1 Enzyme-Linked Immunosorbent Assay 1 Diagnosis 1 Blood Specimen Collection 1 Adenosine Diphosphate Ribose 1 Adenosine Diphosphate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03109080 2025-11-24

RadioPARP

Institut Curie

Phase 1 Completed

Radiation Injuries, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡